HEAR YOUR HEART
Live / Registered — Registered (as of 08 Aug 2023)
What this means for you
Registered since 08 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97163221
- Registration number
- 7134392
- Mark type
- Design + words
- Filed
- 08 Dec 2021
- Published for opposition
- 08 Nov 2022
- Registered
- 08 Aug 2023
- Attorney of record
- Scott J. Major
Goods and services
- Class 035 — Advertising and business services: promotional services by manufacturers of heart and diabetes pharmaceutical products, namely, promoting awareness of heart failure in women and its symptoms, treatment and prevention
- Class 044 — Medical, beauty and agricultural services: providing information by manufacturers of heart and diabetes pharmaceutical products on heart failure in women and its symptoms, treatment and prevention
Owner
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
Prosecution history
- 08 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 04 Jul 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Jul 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Jun 2023 — USE AMENDMENT FILED
- 28 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Jun 2023 — TEAS STATEMENT OF USE RECEIVED
- 03 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Nov 2022 — PUBLISHED FOR OPPOSITION
- 19 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Oct 2022 — EXAMINER'S AMENDMENT ENTERED
- 06 Oct 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED